We offer a unique combination of extensive inhalation device development capability and long experience from pharmaceutical product development.
Dr Orest Lastow, CEO
Dr Orest Lastow
CEO and Head of R&D

PhD, Aerosol Physics

  • Over 25 years of inhalation experience, mainly from AstraZeneca
  • Inventor and former project director of AstraZeneca’s new inhalation product platform including, device development, formulation development, development of analytical methodology, process development, analytical validation and production of clinical trials supply
  • Inventor of 9 different inhalation devices and has worked on 13 different inhalation devices
  • Over 40 patents/patent applications
  • Frequently invited speaker to inhalation conferences and the author behind many publications and books
  • Co-author of ISO standard on inhalation devices
  • Teaches inhaled drug delivery at Lund University, Copenhagen University and Shenyang Pharmaceutical University
  • Previously CEO and founder of MVIC AB (Medicon Valley Inhalation Consortium)

 

Founder 2013

Shares: 846 400

 

Other assignments:
Board member within Lastow Consulting AB and Torna Hällestad Fastighets AB

Dr Mikael Arinder
Vice President Operations

PhD, Organic Chemistry

  • 8 years of inhalation experience, mainly from AstraZeneca
  • 17 years of project portfolio management, project management, and line management experience within pharmaceutical development and medical device development in AstraZeneca, J&J, and Atos Medical
  • Former project director of AstraZeneca’s new inhalation product platform including: device development, formulation development, development of analytical methodology, process development, analytical validation and production of clinical trials supply
  • 15 years business experience of chemistry and analytical development, mainly from AstraZeneca
  • Author of 12 scientific and 8 conference publications
  • Frequently invited as examination board member at Ph.D. dissertations at Lund University
  • PMI member

 

Joined Iconovo 2016

Shares: 4 000

 

Other assignments:

Company with individual ownership Mikael Arinder

Dr Mikael Ekström
Vice President Development

PhD, Physical Organic Chemistry

  • Almost 30 years of pharmaceutical development experience in AstraZeneca, predominantly in inhalation and in nasal delivery, from preclinical phase to Life Cycle Management
  • Various Line Management roles in previous company including leading the Inhalation Pharma Unit at AstraZeneca in Gothenburg consisting of Device, Formulation and Analytical Development
  • Pharmaceutical Project Leader for major projects working in tight collaboration with Clinical, Regulatory etc. in Global Product Teams
  • Former member of IPAC-RS Board of Directors

 

Joined Iconovo 2018

Anna Gallon
CFO

B.Sc in Business Administration

  • BA in Business Administration from University of Lund
  • More than 20 years experience in controlling, financing, accounting, IFRS, management, strategy, legal and tax
  • Long experience as CFO, Finance Manager, Business Controller from mainly SME’s
  • Previous roles include CFO at Hövding and Terranet, both companies listed at Nasdaq First North

 

Joined Iconovo 2019

Shares: 1 400

 

Other assignments:
Owner and board member within Priorat AB
Chairman of Ekonomiska Andelsföreningen Nilstorp

Roger Lassing
VP Business Development

B.Sc. Business Administration and Economics

  • 4 years of experience in Business Development with LEO Pharma. Transaction role involving scouting, evaluation and negotiation of final agreement. Transacted 4 agreements
  • 10 years of experience in Business Development with Nycomed / Takeda as Vice President. Business evaluation and deal structuring of mainly licensing transactions. Owned the business case and the financial deal terms. Involved in 28 transactions, mainly clinical late-stage assets or commercial assets on the market
  • Marketing experience from Respiratory field as Global Brand Manager for Symbicort at AstraZeneca, and as Market Analyst at Astra Draco
  • Product marketing roles at Novo Nordisk in the field of insulin and insulin devices at local, regional and global level. Gave significant experience in the cross-road of drug and device combinations
  • Almost 3 years of experience with McKinsey & Co in the health care practice in Brussels

 

Joined Iconovo 2019

Shares: 3 150

Vesna Åkerberg
Director Pharm. Development

MSc. Biomedical Technology

  • 14 years of inhalation experience, mainly from AstraZeneca
  • 10 years experience from line managerial positions in several companies, mainly from product/process/analytical development
  • Worked with product development within the pharmaceutical industry, mainly within formulation development of dry powder formulations
  • Experience from manufacturing of clinical trial material
  • Experience from various powder filling techniques for DPI
Eva Persson
Pharmaceutical Development

 

  • Over 25 years of inhalation experience, mainly from AstraZeneca
  • Deep experience of developing formulations for dry powder inhalers and other dosage forms from pre-clinical phase to production
  • Solid background in GMP and manufacturing material for clinical trials as well as CMC documentations for CTA and registrations
  • Experience in working with Design Control, Design Verification and Risk Management for Medical Device
Mea Lindsjö
Executive Assistant

 

  • 7 years experience providing efficient secretarial and administrativ support to senior management, mainly from Sydkraft Konsult
  • 20 years experience effectively supporting executive level staff, including the CEO and CFO, mainly from Manpower, E.ON Försäljning and Wise Professionals
  • Direct and support experience in sales and marketing
  • Experience from listed companies E.ON and BE Group
Lars Arvidsson
Device Development

 

  • Over 17 years of inhalation experience, mainly from AstraZeneca
  • Device responsible for many AstraZeneca inhalation products
  • Has worked with over 10 different inhalation devices
  • Injection molding, tooling and polymer design expert
  • Co-inventor of AstraZeneca new DPI platform
  • Over 15 patents/patent applications
Henrik Svedberg
Device Development

MSc. Mechanical Engineering

  • 20 years experience of product development from concept to volume production
  • Experience from developing mobile phones and PTZ surveillance cameras
  • Knowledge in Injection molding and diecasting
Magnus Waldt
Device Development

BSc. Innovation Engineering

  • 25 years of experience within product development and plastic components
  • Long experience from mobile phones and other similar consumer products
  • 12 years working as mechanical design responsible, from concept/early design throughout project execution with requirement setting, evaluating design solutions and design verification
  • Experienced in design of precision parts for high volume production
Fredrik Gunnarson
Analytical Development

BSc. Chemical Engineering

  • 13 years of experience analyzing inhalation products within Analytical chemistry at AstraZeneca
  • Testing everything from concept prototypes to documenting products in GMP for NDA application
  • Developed test equipment and performed testing within AstraZeneca new DPI platform
  • Have worked 5 years within different medical device companies with product development, product testing and design control
Jakob Samsøe
Analytical Development

MSc. in Analytical Chemistry

  • Over 5 years of working experience as analytical chemist in R&D within the pharma industry
  • Developed and validated UHPLC methods
  • Experience in LC-MS
  • Has worked with polymers and small organic molecules
Karin Svensson
Analytical Development

BSc. Chemistry

  • Over 5 years of work experience in the pharmaceutical industry as an analytical chemist mainly within development
  • Experience from working on elastomer based products containing hormones and microbicides
  • Experienced in test method validations and transfers
  • Good knowledge in GMP for the analytical laboratory
Magnus Olsson
Pharmaceutical Development

MSc. in Pharmaceutics

  • Over 30 years experience in pharmaceutical development. Mainly in inhalation development
  • Experienced in formulation- and device-development of Dry Powder Inhalers both for small and large molecules. Covering work from preclinical phase to commercialisation
  • Has worked with wide range of processes including particle size reduction, blending, spray drying and filling
  • Experience in clinical manufacturing, equipment and cleaning validation according to GMP
Nathasha Rizza
Analytical Chemist

MSc. Engineering Biotechnology

  • 1 year of working experience as analytical chemist in QC laboratory within the pharma industry
  • Experience in GC, HPLC, UPLC and device testing
  • Good knowledge in GMP for the analytical laboratory
Carl Forslund
Head of Industrial Design

MFA Industrial Design

  • Co-founder and owner of Zenit Design
  • Creative Director with 20 years of industrial design experience
  • Experience from a wide range of inhalation device design projects
  • Many design protections and patents
  • Winner of Red Dot award
Mats Johansson
Chairman

 

Serial entrepreneur for over 30 years. Extensive experience from starting and developing companies to multimillion turnover and to make IPO´s. Founder of among others ZetaDisplay AB (NASDAQ First North) and MultiQ Int. AB (NASDAQ Stockholm). Board member and chairman in various companies.

Shares: 920 000

Not independent in relation to the Company’s major shareholders, but independent in relation to the Company and the company management.

 

Born 1961
Member of the Board since 2013 (Chairman since 2013)

 

Other assignments:
Chairman of ZetaDisplay AB (publ)
Board member within Fastighetsbolaget Klara Bo, KlaraBo Sverige AB, KlaraBo Bygg AB, KlaraBo Bjuv AB, KlaraBo Svalöv AB , Zenit Design Group AB, SIB Solutions AB and Abrax As Holding AB

Orest Lastow
Board member

PhD, Aerosol Physics

Over 25 years of inhalation experience, mainly from AstraZeneca. Inventor and former project director of AstraZeneca’s new inhalation product. Inventor of 9 different inhalation devices and over 40 patents/patent applications. Author behind many publications and books. Part of developing ISO standards to inhalation devices and nebulizers. Teaches inhaled drug delivery at Lund University, Copenhagen University and Shenyang Pharmaceutical University.
Previously CEO and founder of MVIC AB (Medicon Valley Inhalation Consortium).

Shares: 846 400

Not independent in relation to the Company’s major shareholders, the Company and the company management.

 

Born 1964
Member of the Board since 2013

 

Other assignments:
Board member within Lastow Consulting AB and Torna Hällestad Fastighets AB

 

Management position: CEO Iconovo AB

 

Berndt Axelsson
Board member

MSc in Business and Economics

Long experience from management consulting as Consultant Manager/Director at PwC. Worked with projects in both international groups, startups and family owned companies. Earlier experience as CFO at RH Group. Current CEO at Flokk AB/Vice President for Legal & Risk at Flokk Group.

Shares: 315 600

Independent in relation to larger shareholders, and in relation to the Company and the company management.

 

Born 1959
Member of the Board since 2013

 

Other assignments:
CEO and Board member, Flokk AB
CEO and Board member, Fastighets AB Stolhuset
Owner and Boarder member, Ban Business Consulting AB
Chairman and Board member, Invid Jönköping AB
Chairman and Boarder member, Nässjö Näringsliv AB
Chairman and Boarder member, Malmstolen Produktion AB
Board member, Offecct AB
Board member, Offecct Design AB
Board member, Malmstolen AB

 

Management position: CEO Flokk AB, CEO Fastighet AB Stolhuset, BAN Business Consulting AB

Sven Totté
Board member

MSc, BEc, MBA, cert. Corp. Gov. 

Experienced International Business Manager with a 25-year track record in complex sales & marketing, leadership & organizational development, product strategy, and entrepreneurship in a variety of industries.

Shares: 24 000

Independent in relation to larger shareholders, and in relation to the Company and the company management.

 

Born 1969
Member of the Board since 2017

 

Other assignments:
Board member and CEO, Totté & Co AB
Board member, Century Analytics AB

 

Management position: CEO Totté & Co AB

Agneta Walhagen
Board member

PhD, Analytical Science

Over 26 years of experience working within Research and Development in Pharmaceutical Industry in both preclinical, clinical and commercial development.
Strong inhalation experience from working in AstraZeneca for 20 years in the respiratory area in several senior leadership positions, both as manager/director, project leader and portfolio manager. Since 6 years back been working at LEO Pharma, Denmark, in the dermatology area previously heading Pharmaceutical Technologies, early Business Development and currently Senior Director of R&D Alliance Management.

Independent in relation to the Company’s major shareholders, the Company and the company management.

 

Born 1960
Member of the Board since 2019

 

Other assignments:

Management Position: Senior Director at LEO Pharma

Maria Bech
Board member

MSc Molecular Biology

Has 25 years’ experience in drug development, clinical research and project management in Pharmaceutical companies and the Biotech industry.
Have worked in a number of therapeutic areas such as metabolic diseases, CNS, oncology, pediatrics, endocrinology and nutrition.
Currently independent consultant and board member in a number of companies.

Shares: 2 000

Independent in relation to larger shareholders, and in relation to the Company and the company management.

 

Born 1968
Member of the Board since 2018

 

Other assignments:
Board member, EQL Pharma AB
Board member, Neuronano AB
Board member, Paxman AB
Board member, Bech Pharma Consulting AB

 

Management position: CEO, Bech Pharma Consulting AB

Leif Bergvall Hansen
Board Member

MSc (Copenhagen Business School)

25 years experience from managerial positions in several FMCG companies from blue chip like Nestle to several mid cap companies. Half the time in CEO positions. Have had base in France, UK, US and Denmark.
Currently Group CEO for Scandi Standard a listed leading player in northern Europe within chicken based food products with revenue in excess of 8 BN SEK. Experienced board member.

Shares: 25 974

Independent in relation to larger shareholders, and in relation to the Company and the company management.

 

Born 1966
Member of the Board since 2018

 

Other assignments:
Board member, Farmfood AS
CEO, Bergvall Hansen Holding Aps
Board member, Goodvalley A/S

 

Management position: CEO Scandi Standard AB

Kjell Larsson
Scientific Advisory Board

Professor, Respiratory Medicine

  • 30 years of experience in guidelines production for asthma and COPD treatment
  • 15 years as a member of the Heart and Lung Foundation Research Council, including 4 years as its Vice Chairman
  • Author of more than 200 original papers in international peer reviewed journals
  • Author and editor of several books on asthma and COPD
  • Former Editor in chief of European Respiratory Monograph
Lars-Erik Holm
Scientific Advisory Board

MD, PhD in Oncology

  • He has served as Vice Chair and Chair of the Standing Committee of the WHO European Region and been a member of the Executive Board of WHO
  • Former Director General of the National Board of Health and Welfare and Chief Medical Officer (CMO) in Sweden
  • Former Director General of the Swedish Radiation Protection Authority
  • Former Chaiman of UNSCEAR (United Nations Scientific Committee on the Effects of Atomic Radiation)
  • Has represented Sweden in numerous WHO settings
  • Author of more than 300 scientific articles on epidemiology, prevention and health promotion